Class information for:
Level 1: CANC VACCINE DEV PROGRAM//TUMOR VACCINE GRP//CANC IMMUNOL IMMUNOTHER Y

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
10 4 IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY 1369268
17 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 124793
201 2             IMMUNOTHERAPY//DENDRITIC CELLS//MYELOID DERIVED SUPPRESSOR CELLS 20719
16938 1                   CANC VACCINE DEV PROGRAM//TUMOR VACCINE GRP//CANC IMMUNOL IMMUNOTHER Y 653

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CANC VACCINE DEV PROGRAM address 804383 3% 83% 20
2 TUMOR VACCINE GRP address 520186 5% 34% 32
3 CANC IMMUNOL IMMUNOTHER Y address 418408 4% 30% 29
4 CANC SECT address 413181 4% 34% 25
5 HER 2 NEU PEPTIDES authKW 343204 1% 89% 8
6 HER 2 NEU authKW 338268 15% 7% 95
7 ONCOANTIGENS authKW 337843 1% 100% 7
8 TRANSLAT MED WOMENS HLTH address 311349 3% 32% 20
9 JOYCE MURTHA BREAST CARE address 289580 1% 100% 6
10 IMMUNOPREVENTION authKW 229815 2% 48% 10

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 8105 57% 0% 375
2 Immunology 3599 36% 0% 234
3 Medicine, Research & Experimental 946 15% 0% 99
4 Biotechnology & Applied Microbiology 121 7% 0% 47
5 Genetics & Heredity 53 5% 0% 34
6 Cell Biology 14 5% 0% 30
7 Pathology 4 1% 0% 9
8 Obstetrics & Gynecology 1 1% 0% 8
9 Hematology 1 1% 0% 8
10 Biochemical Research Methods 1 1% 0% 9

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CANC VACCINE DEV PROGRAM 804383 3% 83% 20
2 TUMOR VACCINE GRP 520186 5% 34% 32
3 CANC IMMUNOL IMMUNOTHER Y 418408 4% 30% 29
4 CANC SECT 413181 4% 34% 25
5 TRANSLAT MED WOMENS HLTH 311349 3% 32% 20
6 JOYCE MURTHA BREAST CARE 289580 1% 100% 6
7 RENA ROWEN BREAST 172366 1% 71% 5
8 BIOTECHNOL SATELLITE UNIT BOLOGNA 108591 0% 75% 3
9 CLIN BIOL SCI 104332 10% 3% 67
10 US MIL CANC 97498 2% 14% 14

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CANCER IMMUNOLOGY IMMUNOTHERAPY 22988 7% 1% 46
2 ONCOIMMUNOLOGY 8071 2% 1% 14
3 CANCER RESEARCH 3800 9% 0% 56
4 CLINICAL CANCER RESEARCH 3400 5% 0% 33
5 IMMUNOTHERAPY 3034 1% 1% 7
6 GENE THERAPY 2366 2% 0% 14
7 BREAST CANCER RESEARCH 2139 2% 0% 10
8 INTERNATIONAL JOURNAL OF CANCER 2082 5% 0% 30
9 JOURNAL OF IMMUNOLOGY 1838 7% 0% 46
10 EXPERT REVIEW OF VACCINES 1805 1% 1% 7

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 HER 2 NEU PEPTIDES 343204 1% 89% 8 Search HER+2+NEU+PEPTIDES Search HER+2+NEU+PEPTIDES
2 HER 2 NEU 338268 15% 7% 95 Search HER+2+NEU Search HER+2+NEU
3 ONCOANTIGENS 337843 1% 100% 7 Search ONCOANTIGENS Search ONCOANTIGENS
4 IMMUNOPREVENTION 229815 2% 48% 10 Search IMMUNOPREVENTION Search IMMUNOPREVENTION
5 NELIPEPIMUT S 193053 1% 100% 4 Search NELIPEPIMUT+S Search NELIPEPIMUT+S
6 E75 193037 2% 33% 12 Search E75 Search E75
7 CANCER IMMUNOPREVENTION 154441 1% 80% 4 Search CANCER+IMMUNOPREVENTION Search CANCER+IMMUNOPREVENTION
8 B CELL PEPTIDES 96527 0% 100% 2 Search B+CELL+PEPTIDES Search B+CELL+PEPTIDES
9 CANCER IMMUNOTHERAPEUTIC 96527 0% 100% 2 Search CANCER+IMMUNOTHERAPEUTIC Search CANCER+IMMUNOTHERAPEUTIC
10 E75 PEPTIDE 96527 0% 100% 2 Search E75+PEPTIDE Search E75+PEPTIDE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 27441 RAS DERIVED PEPTIDES//P53 PEPTIDES//RAS PEPTIDES
2 11302 TUMOR IMMUNOL BIOL//SIPULEUCEL T//PROSTVAC
3 1356 CANCER TESTIS ANTIGEN//NY ESO 1//MAGE
4 31085 GV1001//UNITE VIROL MOL VECTOROL//VAXON BIOTECH
5 1360 HER 2 NEU//C ERBB 2//HER2
6 24410 CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE
7 3197 TRASTUZUMAB//LAPATINIB//PERTUZUMAB
8 36129 LAG 3//LYMPHOCYTE ACTIVATION GENE 3//CD223
9 8742 TUMOR INFILTRATING LYMPHOCYTES//TERTIARY LYMPHOID STRUCTURES//FOXP3
10 548 DENDRITIC CELLS//IMMUNOTHERAPY//TUMOR LYSATE

Go to start page